Sign Up to like & get
recommendations!
0
Published in 2018 at "Current Treatment Options in Cardiovascular Medicine"
DOI: 10.1007/s11936-018-0618-y
Abstract: Purpose of reviewMultiple myeloma treatment regimens consist of proteasome inhibitors (bortezomib, carfilzomib, and ixazomib), immunomodulatory drugs (thalidomide, lenalidomide, and pomalidomide), and steroids. In this paper, we will review the pathophysiology and associated cardiotoxicities of the…
read more here.
Keywords:
myeloma;
cardiovascular complications;
treatment;
multiple myeloma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.16124
Abstract: Limited data are available regarding contemporary multiple myeloma (MM) treatment practices in Latin America. In this retrospective cohort study, medical records were reviewed for a multinational cohort of 1103 Latin American MM patients (median age,…
read more here.
Keywords:
multiple myeloma;
latin america;
myeloma treatment;
based therapy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Oncology nursing forum"
DOI: 10.1188/23.onf.372-380
Abstract: OBJECTIVES To examine factors that lead to the facilitation of multiple myeloma (MM) treatment. SAMPLE & SETTING 29 patients who had been diagnosed with MM at Mount Sinai Hospital in New York City. METHODS &…
read more here.
Keywords:
oncology;
myeloma treatment;
support;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e20016
Abstract: e20016Background: With the emergence of immunotherapy, genomics, and precision medicine, the future of multiple myeloma (MM) treatment is rapidly evolving. We reviewed the efficacy of (non-FDA appr...
read more here.
Keywords:
multiple myeloma;
myeloma treatment;
emerging immunotherapy;